Archives Oligomerix, Inc. Awarded National Institute on Aging SBIR Grant for Development of Alzheimer’s Disease Specific Biomarker September 7, 2017 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix Awarded a Grant for its Alzheimer’s Drug Discovery Program Targeting Tau Oligomers from the National Institutes of HealthNext →Oligomerix Inc. Awarded 2.49 Million Fast-Track
